Coronary bioresorbable vascular scaffold use in the treatment of coronary artery disease (vol 9, e003978, 2016)

Testa L.; Latib A.; Montone R. A.; Colombo A.; Coronary Bedogni F.

首页> 外文期刊>Circulation. Cardiovascular interventions >Coronary bioresorbable vascular scaffold use in the treatment of coronary artery disease (vol 9, e003978, 2016)

【24h】

Coronary bioresorbable vascular scaffold use in the treatment of coronary artery disease (vol 9, e003978, 2016)

机译：冠状动脉生物可吸收血管支架在治疗冠状动脉疾病中的应用（第9卷，e003978，2016）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Circulation. Cardiovascular interventions》 |2016年第8期|共1页
作者
Testa L.; Latib A.; Montone R. A.; Colombo A.; Coronary Bedogni F.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Coronary bioresorbable vascular scaffold use in the treatment of coronary artery disease (vol 9, e003978, 2016) [J] . Testa L., Latib A., Montone R. A., Circulation. Cardiovascular interventions . 2016,第8期

机译：冠状动脉生物可吸收血管支架在治疗冠状动脉疾病中的应用（第9卷，e003978，2016）
2. ABSORB II randomized controlled trial: A clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: Rationale and study design [J] . DilettiR., SerruysP.W., FarooqV., The American heart journal . 2012,第5期

机译：ABSORB II随机对照试验：一项临床评估，比较Absorb洗脱依维莫司洗脱生物可吸收血管支架系统与XIENCE依维莫司洗脱冠状动脉支架系统在治疗从新引起的缺血性心脏病中的安全性，疗效和性能天然冠状动脉病变：原理和研究设计
3. First US Experience Following FDA Approval of the ABBOTT Vascular Bioresorbable Vascular Scaffold for the Treatment of Coronary Artery Disease [J] . Rizik David G., Shah Maulik G., Burke Robert F. Catheterization and cardiovascular interventions: Official journal of the Society for Cardiac Angiography & Interventions . 2016,第6期

机译：首先在FDA批准雅培血管生物可吸收血管支架的FDA批准用于治疗冠状动脉疾病
4. A non-toxic additive to introduce X-ray contrast into poly(lactic acid). Implications for transient medical implants such as bioresorbable coronary vascular scaffolds [C] . Yuiing Wang, Leo H. Koole Society for Biomaterials annual meeting and exposition . 2013

机译：将X射线造影剂引入聚乳酸的无毒添加剂。对暂时性医疗植入物（如可生物吸收的冠状动脉支架）的影响
5. Treatment Decision Making in Multivessel Coronary Artery Disease [D] . Nichols, Elizabeth L. 2018

机译：多支冠状动脉疾病的治疗决策
6. The 1‑year safety and efficacy outcomes of Absorb bioresorbable vascular scaffolds for coronary artery disease treatment in diabetes mellitus patients: the ABSORB DM Benelux study [O] . T. M. Hommels, R. S. Hermanides, S. Rasoul, 2019

机译：ABSORB DM比荷卢经济联盟研究可吸收生物可吸收血管支架治疗糖尿病患者的冠状动脉疾病的1年安全性和有效性结果
7. Coronary Bioresorbable Vascular Scaffold Use in the Treatment of Coronary Artery Disease [O] . Luca Testa, Azeem Latib, Rocco A. Montone, 2016

机译：冠状动脉性血管支架用于治疗冠状动脉疾病

Coronary bioresorbable vascular scaffold use in the treatment of coronary artery disease (vol 9, e003978, 2016)

著录项

相似文献

相关主题

期刊订阅